Invivyd Inc — Quarterly Financial Statistics (NASDAQ:IVVD)

Financials

Cash from operating activities -37.61 M-21.13 M-13.3 M-8.25 M-15.46 M -58.13 M Cash from investing activities 5 000-144 K-11 K00 -155 K Cash from financing activities 77 K10 K131 K58.31 M157.18 M 215.63 M Free cash flow -37.6 M-21.27 M-13.31 M-8.25 M-15.46 M -58.29 M

Nouvelles

Invivyd: Why The Trial Upsizing Isn't The Green Light Bulls Think It Is (NASDAQ:IVVD)

H.C. Wainwright réitère sa recommandation sur Invivyd suite au programme contre la rougeole

Invivyd, Inc. (IVVD) Discusses Progress in REVOLUTION Clinical Program and Advancement of Measles Monoclonal Antibody Candidate - Slideshow (NASDAQ:IVVD) 2026-04-09

Invivyd, Inc. (IVVD) Discusses Progress in REVOLUTION Clinical Program and Advancement of Measles Monoclonal Antibody Candidate Transcript

L’action Invivyd bondit de 25% suite aux progrès de l’essai COVID-19

La hausse des actions d'Invivyd suite à l'alignement de la FDA stimule son programme COVID-19 | Benzinga France

Invivyd augmente son essai COVID-19, cible un anticorps contre la rougeole

Invivyd, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IVVD) 2026-03-08

Invivyd, Inc. (IVVD) Q4 2025 Earnings Call Transcript

Invivyd T4 2025 : le chiffre d’affaires bondit de 31%, le pipeline progresse

Invivyd Q4 2025 slides: revenue surges 31%, pipeline advances

Le BPA de Invivyd a dépassé les attentes de 0,11$, le CA a surpassé les prévisions